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ABBREVIATIONS: [AMD1] (S-adenosylmethionine decarboxylase proenzyme), [ARG1] 1 
(Arginase1), [DFUs] (Diabetic foot ulcers), [Nor-NOHA] (Nomega-hydroxy-nor-L-arginine), 2 
[NOS] (Nitric Oxide Synthase, [OAT] (Ornithine amino transferase), [ODC] (Ornithine 3 
decarboxylase), [ovx] (ovariectomized) 4 
 5 
ABSTRACT 6 
Non-healing wounds are a major area of unmet clinical need remaining problematic to treat. 7 
Improved understanding of pro-healing mechanisms is invaluable. The enzyme arginase1 is 8 
involved in pro-healing responses with its role in macrophages best characterized. Arginase1 9 
is also expressed by keratinocytes; however, arginase1 function in these critical wound repair 10 
cells is not understood. We characterized arginase1 expression in keratinocytes during normal 11 
cutaneous repair and reveal de novo temporal and spatial expression at the epidermal wound 12 
edge. Interestingly, epidermal arginase1 expression was decreased in both human and murine 13 
delayed healing wounds. We therefore generated a keratinocyte specific arginase1-null 14 
mouse model (K14-cre;Arg1
fl/fl
) to explore arginase function. Wound repair, linked to 15 
changes in keratinocyte proliferation, migration and differentiation, was significantly delayed 16 
in K14-cre;Arg1
fl/fl
 mice. Similarly, using the arginase inhibitor nor-NOHA, human in vitro 17 
and ex vivo models further confirmed this finding, revealing the importance of the 18 
downstream polyamine pathway in repair. Indeed, restoring the balance in arginase1 activity 19 
via addition of putrescine, proved beneficial in wound closure. In summary, we demonstrate 20 
that epidermal arginase1 plays a, to our knowledge, previously unreported intrinsic role in 21 
cutaneous healing, highlighting epidermal arginase1 and downstream mediators as potential 22 
targets for the therapeutic modulation of wound repair.  23 
 24 











Non-healing wounds including pressure, diabetic, venous ulcers and non-healing surgical 2 
wounds, are a significant health burden (Harding et al., 2002), characterized by excessive 3 
inflammation and defective re-epithelialization. Numerous factors have been implicated in 4 
defective wound healing, including altered levels of the arginine metabolic enzyme, 5 
arginase1. Arginine metabolism is involved in numerous processes including; immune 6 
regulation  (Bronte and Zanovello, 2005, Tong and Barbul, 2004); the Krebs cycle; the urea 7 
cycle; growth hormone secretion; cell proliferation (Bronte et al., 2003, Li et al., 2002, Ochoa 8 
et al., 2001, Pegg and McCann, 1982) and collagen synthesis (Barbul, 2008). The effect on 9 
these processes depends on how L-arginine is metabolized and the balance of the competitive 10 
arginine catabolic enzymes- nitric oxide synthase (NOS) and arginase1. NOS metabolism of 11 
arginine leads to citrulline and nitric oxide (NO) production - important in the early pro-12 
inflammatory phase of repair, including anti-microbial effects and cell death. In contrast, 13 
arginase1 metabolism of arginine has two primary functions; detoxification of ammonia via 14 
the urea cycle and production of ornithine, which is known to be critical for the pro-healing 15 
response. Ornithine decarboxylase (ODC) metabolism of ornithine leads to polyamine 16 
synthesis (putrescine, spermidine and spermine), involved in epithelial stem cell function, cell 17 
proliferation and differentiation (Pietila et al., 2005, Ramot et al., 2011). Alternatively, 18 
ornithine amino transferase (OAT) metabolism of ornithine, promotes proline production, 19 
involved in collagen synthesis (Jenkinson et al., 1996, Witte et al., 2002). Thus, multiple 20 
facets of arginase1 activity are linked with the repair response. 21 
 22 
Conflicting reports of arginase’s impact on healing are likely due to its involvement in many 23 
aspects of the healing response. Dysregulation of arginase and pathway components are 24 










(Kim et al., 2009, Ming and Yang, 2013, Moretto et al., 2019, Muller et al., 2008), chronic 1 
wounds and delayed healing (Abd-El-Aleem et al., 2000, Jude et al., 1999, Sindrilaru et al., 2 
2011). Down-regulation of ARG1 gene expression has been linked to age-associated human 3 
(Hardman and Ashcroft, 2008) and murine delayed healing (Campbell et al., 2013); 4 
conversely, increased arginase activity was reported in diabetic wounds (Kampfer et al., 5 
2003). Similarly, mechanistic mouse studies report conflicting effects on wound repair 6 
showing both improved (Kavalukas et al., 2012) and delayed healing (Campbell et al., 2013) 7 
when arginase activity was inhibited either globally or in macrophages. Thus, although it is 8 
clear arginase plays a major role in wound healing, further investigation into the role of 9 
arginase1 in cutaneous repair is needed. Indeed, the apparent discrepancies between 10 
published studies suggest cell and wound-type specific roles in healing.  11 
 12 
Arginase1 is best characterized in activated ‘anti-inflammatory’ (M2) macrophages, and 13 
studies on cutaneous arginase1 function is almost exclusively confined to its role in 14 
macrophages (Mahdavian Delavary et al., 2011). Arginase1 is however, also expressed in 15 
other prominent wound cell types including keratinocytes (Bruch-Gerharz et al., 2003). On 16 
cutaneous wounding the keratinocytes at the wound edge proliferate and migrate during re-17 
epithelialization to close the wound and these processes are frequently impaired in chronic 18 
wounds. In normal healing, keratinocytes will then differentiate to stratify the newly formed 19 
epidermis, releasing factors such as lipids, cytokines and anti-microbial products to restore 20 
skin barrier integrity and contribute to immune defence (Coulombe, 1997, Pastar et al., 2014). 21 
Although arginase1 has been implicated in functions associated with epidermal repair, the 22 
role of epidermal arginase1 is poorly understood. Moreover, the functional relevance of 23 











This study aimed to determine the epidermal specific role of arginase1 in cutaneous wound 1 
repair. We hypothesized that, keratinocyte specific defects in arginase1 function, contribute 2 
to pathological healing. To test this hypothesis, we determined epidermal arginase1 3 
expression profiles in human and murine delayed healing models and developed a 4 
keratinocyte-specific arginase1 null mouse.  5 
 6 
RESULTS AND DISCUSSION 7 
Epidermal arginase1 is temporally induced during cutaneous healing 8 
To define the role of epidermal arginase1 in cutaneous healing we characterized temporal and 9 
spatial arginase expression in wound edge keratinocytes during acute wound repair using 10 
immunohistochemical (IHC) analysis (Figure 1). Low arginase1 expression was observed in 11 
the unwounded epidermis (Supplementary Figure S1); however, expression was high at the 12 
wound edge and peri-wound epidermis, specifically the suprabasal layers of the wound edge 13 
epidermis, of both human (Figure 1a) and murine (Figure 1b) acute wounds. Arginase1 14 
immunofluorescence (IF) analysis of murine acute wounds, showed low arginase1 wound 15 
epidermal expression at 1day post-wounding (indicated by co-localization with keratin14 16 
(K14)).  By day 3, arginase1 was highly induced in the suprabasal layers of the neo-epidermis 17 
and peri-wound epidermis. Expression remained high at day 5, but almost completely 18 
disappeared by day 7 and was undetectable at 14days post-wounding, when the 19 
hyperproliferative wound epidermis had almost completely resolved (Figure 1c, d). 20 
Interestingly, this expression pattern of epidermal arginase during the proliferative, 21 










Epidermal arginase1 expression is reduced in delayed healing wounds 1 
Arginase1 was assessed in human chronic wounds; ovariectomized (ovx) and age-matched 2 
intact controls (Emmerson et al, 2012); and aged murine models of delayed healing. In 3 
murine delayed healing wounds (ovx and aged) arginase1 was significantly reduced at 3days 4 
post-wounding compared to intact and young (7week old) controls, respectively (Figure 2a-d, 5 
Supplementary Figure S2). This finding was mirrored in human chronic DFUs whereby, 6 
arginase1 expression was reduced at initial clinical presentation in wounds that failed to heal 7 
within 12weeks, compared to those that healed within 8weeks of clinical assessment (Figure 8 
2e-g). The distinct localization in acute wounds contrasted with arginase1 expression 9 
observed throughout the epidermis in DFUs (Figure 2f,g), perhaps more akin to increased 10 
levels of global arginase typically reported in chronic wounds (Abd-El-Aleem et al., 2000, 11 
Jude et al., 1999, Wessagowit et al., 2004). These findings appear to contradict previous work 12 
demonstrating heightened arginase1 expression throughout the epidermis in chronic venous 13 
leg ulcers (Abd El-Aleem et al., 2020). One explanation for this is that the published data 14 
compared epidermal arginase expression at the ulcer edge with normal epidermis away from 15 
the ulcer edge. Alternatively, these observations may reflect the arginase1 expression we 16 
observed in DFUs that subsequently healed (Figure 2), illustrating the importance of 17 
longitudinal sampling where possible. Nevertheless, our data implicate dysregulation of 18 
epidermal arginase1 in defective healing. Future studies could explore this dynamic 19 
expression using diabetic models such as the db/db mouse, to further our understanding. 20 
 21 
Epidermal specific deletion of arginase1 delays acute murine healing 22 
We made a keratinocyte specific arginase1 knockout mouse model (K14cre;Arg1
fl/fl
). To 23 
confirm the depletion we performed PCR (Supplementary Text), arginase assay and IHC 24 










depletion and critically the specificity of depletionwhilst retaining dermal arginase1 1 
expression (Figure 3a).  Furthermore, the observation of reduced global arginase activity 2 
(Figure 3b), implicates keratinocytes as a major source of arginase1 during repair. 3 
Histological characterization showed the skin of unwounded K14cre;Arg1
fl/fl 
mice appeared 4 
akin to cre controls in most parameters assessed including H+E, keratin14, 10 and 6, 5 
proliferation and apoptosis, with the exception of loricrin, which was reduced in 6 
K14cre;Arg1
fl/fl 
unwounded skin (Supplementary Figure S3).  7 
 8 
We observed an overall delay in healing in the K14cre;Arg1
fl/fl 
 mice compared to cre 9 
controls. Histo-morphometric quantification of wound area demonstrated significantly larger 10 
wounds (Figure 3c, d), an altered immune response and immune cell composition 11 
(Supplementary Figure S4) and significantly reduced re-epithelialization at 3days post-12 
wounding (Figure 3e, f) in the K14cre;Arg1
fl/fl 
 wounds compared to controls, which was 13 
recapitulated in vitro (Supplementary Figure S5). These results demonstrate that epidermal 14 
arginase1 is important for timely cutaneous wound repair, impacting both dermal and 15 
epidermal responses.   16 
 17 
To determine how arginase1 influences healing, a microarray of laser capture micro-18 
dissected, 3day neo-epidermal wound tissue was performed. The most significant gene 19 
alterations observed in the K14cre;Arg1
fl/fl 
 wounds compared to control were associated with 20 
decreased cell-cycle progression and cell viability (Figure 3g). Changes in genes associated 21 
with an altered immune response were also identified, including cytokines, chemokines and 22 
host microbial response genes (Supplementary Figure S4d-f). Given the marked effects of 23 
arginase1 deletion on re-epithelialization we investigated arginase1 in keratinocyte 24 











Arginase1 is required for effective regulation of keratinocyte proliferation 2 
Upon injury, keratinocytes become activated, priming cells to proliferate and migrate to seal 3 
the open wound. Microarray data implicated proliferation and cell-cycle progression as being 4 
impacted in the absence of keratinocyte arginase. In vivo wounds showed the absence of 5 
keratinocyte arginase1, in K14cre;Arg1
fl/fl
 mice, resulted in reduced activation and 6 
proliferation of keratinocytes at 3days post-wounding (Figure 4). Quantification of keratin6 7 
(K6) staining (Figure 4a-c), a marker of hyper-proliferation and keratinocyte ‘activation’, 8 
demonstrated a significantly reduced distance of K6 expression extending from the wound 9 
edge at 3days post-wounding compared to cre controls (Figure 4b). Similarly, there was a 10 
significant reduction of expression of the proliferation marker, Ki67 (Figure 4d) in the neo-11 
epidermis (Figure 4e) and basal keratinocytes (Figure 4f), observed specifically at the wound 12 
edge (Figure 4g), with a lesser effect observed extending to the peri-wound epidermis (Figure 13 
4h) in K14cre;Arg1
fl/fl
 compared to cre controls at 3days post-wounding. 14 
. Our findings are supported in a recent paper that showed localization of epidermal arginase1 15 
in proliferative keratinocytes in skin remote to the wound edge and throughout the epidermis 16 
at the ulcer edge in chronic venous leg ulcers (Abd El-Aleem et al., 2020). Our analysis of 17 
DFUs (Figure 2e-g) showed similar results with arginase1 expression throughout the 18 
epidermis implying a role for arginase1 in the hyperproliferative epidermal phenotype of 19 
chronic wounds.  20 
 21 
A lack of epidermal arginase1 delays keratinocyte stratification  22 
Regulation of epidermal proliferation and differentiation are interlinked and during re-23 
epithelialization keratinocytes away from the leading edge stop proliferating and start to 24 










high in the differentiated suprabasal wound edge epidermal keratinocytes in vivo (Figure 1 1 
and 5a) and the differentiation marker loricrin, in K14cre;Arg1
fl/fl
, was decreased in 2 
unwounded skin (Supplementary Figure S3). Furthermore, during acute wound repair the 3 
suprabasal arginase1 expression in the neo-epidermis was co-localized with differentiation 4 
markers keratin 10, filaggrin and loricrin (Figure 5a).  ARG1 mRNA levels were also 5 
increased upon in vitro differentiation of keratinocytes to a similar level as KRT10, FLG and 6 
LOR (Figure 5b), suggesting a possible role for arginase in epidermal differentiation. Indeed, 7 
other studies have shown that K10 and profillagrin contain high levels of arginine residues 8 
and during epidermal remodelling these proteins undergo deamination which produces 9 
citrulline and releases free amino acids including arginine (Mechin et al., 2007) - the 10 
substrate for arginase. Citrulline is both a product of L-arginine metabolism by NOS and a 11 
substrate for L-arginine de novo synthesis (Wu and Morris, 1998), therefore providing greater 12 
levels of arginine substrate in differentiating cells which could explain elevated arginase1 13 
levels. Arginase1 may also act as a precursor to keratinocyte differentiation as arginase1 14 
metabolic products such as proline are major components of cornified envelope proteins 15 
(Hohl et al., 1995) and polyamines are required for keratinocyte differentiation (Anisa B. 16 
Rahim, 2021). Indeed, IHC analysis of the differentiation associated markers K10 and 17 
loricrin in acute mouse wounds (Figure 5c), demonstrated significantly reduced epidermal 18 
differentiation by 7days post-wounding in K14cre;Arg1
fl/fl
 wounds compared to control with 19 
reduced loricrin (Figure 5d, e), a major differentiation associated cornified envelope protein 20 
(Kalinin et al., 2002, Koch et al., 2000). Loricrin was also reduced in unwounded skin of 21 
K14cre;Arg1
fl/fl
 mice (Supplementary Figure S3). Notably, hyperkeratosis and parakeratosis 22 
are characteristic of chronic wound keratinocytes (Stojadinovic et al., 2005), due to 23 
dysregulation of differentiation (Stojadinovic et al., 2008). Collectively, these results support 24 










altered epidermal arginase levels impact normal differentiation and the chronic wound 1 
phenotype. 2 
 3 
Manipulating the balance of arginase activity restores healing in human models of 4 
cutaneous repair 5 
Arginase1 metabolizes Arginine into ornithine, a precursor to proline or putrescine, required 6 
for the synthesis of polyamines, spermidine and spermine (Latour et al., 2020). Decreased 7 
arginase will lead to depletion of putrescine and polyamines, known to be important for 8 
wound healing. Polyamine levels and regulators of polyamine production including ODC1 9 
and AMD1 are upregulated at the wound edge (Lim et al., 2018, Maeno et al., 1990, Mizutani 10 
et al., 1974, Shi et al., 2002). Spermine and spermidine  are essential for cell migration and 11 
promote directed migration (Nakajima et al., 2015, Tai et al., 2018) (Lim et al., 2018). To 12 
determine if impaired re-epithelialization during wound healing caused by arginase inhibition 13 
is a consequence of decreased polyamine levels, we assessed whether putrescine could rescue 14 
the wound-healing phenotype. Additon of arginase inhibitor nor-NOHA delayed wound 15 
closure in a keratinocyte scratch assay which was rescued with the addition of putrescine 16 
(Figure 6a, b). Topical application of nor-NOHA to a human wound explant led to reduced 17 
wound re-epithelialization that was also restored with putrescine (Figure c, d). These data 18 
suggest that, on wounding, arginase functions, at least in part, to promote putrescine levels 19 
which are required for wound closure. However, while supplementation with putrescine 20 
rescued the arginase inhibition phenotype, when added in the presence of arginase, putrescine 21 
inhibited wound closure in in vitro and ex vivo models (Figure 6). Similarly, previous reports 22 
have demonstrated high putrescine levels inhibit scratch wound closure (Anisa B. Rahim, 23 
2021, Lim et al., 2018). Together these data suggest that arginase plays a crucial role in 24 










polyamines spermine and spermidine, which in turn control the balance between proliferation 1 
and cell migration. Importantly, the ability to restore the balance in arginase and polyamine 2 
activity leading to rescue of the delayed healing response, demonstrates the therapeutic 3 
potential in manipulating the arginase pathway for improved healing of chronic wounds.  4 
 5 
We propose disparate roles for arginase1 in epidermal remodelling, where timing of 6 
expression is key to determining healing outcome. This is supported by the expression profile 7 
of epidermal arginase1 observed during acute healing, whereby arginase1 is upregulated (D3-8 
7 post-wounding) when epidermal remodelling, including proliferation and migration are at 9 
their peak. Furthermore, wound analysis showed heightened epidermal keratinocyte 10 
activation at 7days post-wounding in K14cre;Arg1
fl/fl
 acute wounds compared to cre controls. 11 
Such observations suggest a late proliferative response, concomitant to a delay in the early 12 
keratinocyte epidermal response, implicating a compensation mechanism. Indeed this lack of 13 
early keratinocyte arginase response, followed by an extended late response, corresponds to 14 
the typical chronic wound epidermal phenotype, that is hyperproliferative yet non-migratory. 15 
Thus, the timing of arginase induction in keratinocytes may be critical in eliciting an early 16 
wound response, with epidermal arginase levels potentially being a predetermining factor of 17 
healing outcome. As heightened arginase1 expression was more localized to the suprabasal 18 
layers of the peri-wound and neo-epidermis it seems unlikely that it  directly influences 19 
proliferation at the wound edge. High levels of arginase indicate high levels of putrescine, 20 
which in turn is typically converted to spermidine and spermine (Supplementary Figure S6). 21 
When spermidine and spermine levels are too high they are either converted back to 22 
putrescine or spermidine with the release of H202, or are acetylated and secreted (Wallace and 23 
Mackarel, 1998). Thus, we would suggest that epidermal arginase influences proliferation in 24 










polyamines could act directly by extracellular polyamine influx into basal proliferating cells, 1 
and/or indirectly via the impact of polyamines altering epidermal and/or dermal specific 2 
immune responses (Lou et al., 2020).  3 
 4 
Collectively, our data demonstrates a positive correlation between early arginase1 expression 5 
and healing outcome, consistent across multiple models of both murine and human cutaneous 6 
healing. We also revealkeratinocyte-specific roles for arginase1 in wound cellular 7 
proliferation, migration and differentiation. We note that these processes are frequently 8 
dysregulated in chronic wounds, positioning the epidermal arginase1 pathway as an exciting 9 











MATERIALS AND METHODS 1 
Full details are given in Supplementary Text linked to the online version. 2 
 3 
Human acute and chronic wounds 4 
Clinical investigation was conducted according to the Declaration of Helsinki principles. 5 
Human studies were approved by the University of Manchester’s Research Ethics Committee 6 
(REC) under 07/Q1406/14 or 13/SC/0499 REC approval, and with written informed consent. 7 
Acute wound 1.5 mm punch biopsies were collected from 3 healthy volunteers (male, aged 8 
≥30 years) (Thomason et al., 2012). Chronic wound biopsy samples from 19 patients (mixed 9 
sex, aged ≥40 years) with chronic DFU (Williams et al., 2018). Ex vivo methodology culture 10 
of skin wound explants was adapted from (Stojadinovic and Tomic-Canic, 2013) and via 11 
communication with Dr David Ansell.  12 
 13 
Murine wounding 14 
Animal studies were conducted according to the Animals (Scientific Procedures) Act 1986 15 
under project licences 70/8136 and 40/3713 approved by the UK Home Office. A 16 
keratinocyte specific arginase1-null mouse model (K14-cre;Arg1
fl/fl
) was generated for this 17 





 (wild-type controls), female C57BL/6J 6-8week old (young), 18month old (aged) 19 
or 10-week ovariectomised (bilateral ovariectomy performed 3 weeks before wounding) mice 20 
received two 1cm full-thickness dorsal incisions and left to heal by secondary intention 21 
(Ashcroft et al., 2003, Emmerson et al., 2012). Tissue harvest was performed at 1, 3, 5, 7 and 22 












Histology and immunohistochemistry  1 
Histological sections were prepared as (Campbell et al., 2013). Briefly, paraffin embedded 2 
sections were stained with H+E or subjected to IHC or IF analyses against the following 3 
markers; arginase, NOS2, keratin6, kertain14, loricrin, keratin10, filaggrin, Ki67, Neutrophil, 4 
Mac3 (Supplementary Table S1).  5 
 6 
For IHC, antibody staining was detected using the Vector Elite ABC Kits (Rabbit, Rat, Goat) 7 
visualized with NOVA Red and IF stained sections were visualized using fluorescent 8 
secondaries (donkey anti-goat AF594; donkey anti-rabbit AF488; Abcam, Cambridge, UK,), 9 
counterstained with DAPI (ThermoFisher Scientific, Loughborough, UK). TUNEL staining 10 
was performed using the in Situ Cell Death Detection Kit Fluorescein (Roche, Welwyn 11 
Garden City, UK) according to manufacturers’ instructions. Analysis was performed blinded 12 
by two independent investigators. Refer to Supplementary text for details on analytical 13 
methods performed for each stain. 14 
 15 
Arginase activity assay 16 
Total wound arginase activity was assessed by the quantification of urea production via the 17 
metabolizm of L-arginine by arginase, modified from (Corraliza et al., 1994). To normalize 18 
the samples, the protein concentration in cell lysates was measured using a BCA Protein 19 
Assay Kit. (ThermoFisher Scientific). 20 
 21 
Microarray  22 
Laser Capture Microdissection (LCM) was used to isolate neo-epidermis cells from 3day 23 
incisional wounds. RNA was isolated using the RNAqueous-Micro Kit (AM1931; Ambion, 24 










frozen wound sections, were processed by the Genomic Technologies Core Facility in the 1 
Faculty of Biology, Medicine and Health, University of Manchester, for microarray analysis, 2 
using the mouse Clariom D Assay (Applied Biosystems).  3 
 4 
In vitro cell analysis 5 
Keratinocyte culture  6 
Normal human epidermal keratinocytes (NHEKs) isolated from juvenile foreskin (Promocell) 7 
were cultured in keratinocyte growth medium 2 (Promocell) at 37°C with 5% CO2. NHEKs 8 
were used in experiments at P3-5. N/TERT-1 cells were cultured at 37°C with 5% CO2 in 9 
Keratinocyte Serum Free Media as previously described (Lim et al., 2018) and transferred to 10 
DFK-2 media  and K-SFM, all from GIBCO). HaCaT cells (ATCC12191) were cultured in 11 
DMEM (high glucose) with 10% FBS and 1x Pen/Strep at 37°C with 5% CO2. 12 
 13 
Keratinocyte scratch assay  14 
HaCaT cells were seeded into 24well plates, cultured until confluent, then scatched with a 15 
1ml sterile pipette tip. 0hr controls were immediately stained with crystal violet, while nor-16 
NOHA or untreated wells were incubated for 24hrs before staining. Three images/well were 17 
captured using a Nikon Eclipse E600 microscope and SPOT insight camera (Image solutions 18 
Inc, Preston, UK). An average of 5 measurements/image from 3 images/well were used to 19 
calculate percentage wound width remaining using Image Pro Plus software (Media 20 
Cybernetics, Abingdon, UK). N/TERT-1 cells seeded at a density of 1x10
4 
cells/well 21 
incubated for 3days in Keratinocyte Serum Free Media, 2days in DFK-2 before treatment 22 
with nor-NOHA 5µM (Cayman, Michigan, USA) or Putrescine 10µM (Sigma) in DFK-2 for 23 
24 or 48hrs prior to scratch. Confluent monolayers were scratched with an Essen wound 24 










added and cells were imaged every 2hr with the Incucyte system. Assay was performed in 1 
biological triplicate. Percentage wound closure was calculated based on scratch width after 2 
the specified duration, relative to initial width.  3 
 4 
Differentiation assay  5 
NHEKs were seeded into 6well plates at 4x10
5
 cells/well. At ~60% confluence, cells were 6 
transitioned over 2days into CNT-PR culture media, prior to switching to defined 7 
differentiation media CNT-PR-D (CellnTech). Cells were collected before the switch and 2, 8 
4, and 6days after.  9 
 10 
Quantitative real-time PCR 11 
Total RNA was isolated from NHEKs by Trizol/Chloroform extraction and column based 12 
purification using the Purelink RNA mini kit (Invitrogen, Paisley, UK).  13 
 14 
Statistical analysis 15 
Ordinary or repeated measures two-way ANOVA followed by Sidak’s multiple comparisons 16 
test was performed for all grouped data with two factors (1. genotype/treatment and 2. time) 17 
and adjusted P values reported. If normality could not be assumed, statistical comparisons 18 
between groups was determined using the Mann-Whitney test at each timepoint and the two-19 
tailed P value reported. Ordinary one-way ANOVA was used for single factor data with 3 or 20 
more groups followed by Tukey’s multiple comparisons; or Kruskal Wallis test with Dunn’s 21 
multiple comparisons if normality could not be assumed. Single factor data with less than 3 22 
groups were analyzed using the unpaired t-test and the two-tailed P value reported. All 23 
analysis was performed using GraphPad Prism 8 Version 8.4.2 (GraphPad Software, Inc. CA, 24 
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FIGURE LEGENDS 1 
Figure 1. Temporal epidermal arginase1 expression during cutaneous wound repair.  (a) 2 
Representative IHC arginase1 staining of acute human (dashed line indicates basement 3 
membrane) and (b) mouse day 3 incisional wounds. Scale bar = 400µm (zoomed image 4 
100µm). (c) Quantification and (d) representative IF staining of epidermal arginase1 5 
expression in acute murine incisional wounds, yellow arrows indicate arginase1 epidermal 6 
staining. Keratin 14 shows the epidermal layers of the skin. White arrows indicate the dermal 7 
wound edge and white dashed lines outline the basement membrane (Red=K14; 8 
Green=Arginase1; Blue=Dapi; Scale bar = 50µm; n=4 or 6 human wounds or mice/group 9 
respectively).  10 
 11 
Figure 2. Epidermal arginase1 expression is reduced in impaired healing. (a) 12 
Representative IHC arginase1 expression from young intact and ovariectomized (ovx) 3day 13 
murine wounds (Scale=100µm) and (b) quantification. (c) Epidermal arginase1 expression in 14 
aged versus young murine wounds at 3days post-wounding. Yellow arrows indicate arginase1 15 
epidermal staining; white arrows the wound edge (Scale=50µm; n=5 mice/group). (d) 16 
Quantification of epidermal arginase1 expression in aged versus young 3day wounds. (e) 17 
Human DFUs obtained at presentation were analysed for arginase1 expression then grouped 18 
by length of time to heal (Healed <8weeks; Non-Healed >12weeks from initial visit). 19 
Arginase1 expression was quantified in healed and non-healed DFUs (f) and representative 20 
staining is shown in (g; Scale=50µm). Mean±SEM; n=6 patients with healed wounds and 21 
n=13 non-healed wounds; Red=K14; Green=Arginase1; Blue=Dapi; dashed white lines 22 











Figure 3. Epidermal arginase1  is essential for timely healing. (a) Representative 1 





mice (solid black arrows indicate epidermal arginase1 stain; open arrows indicate dermal 3 
arginase1 positive cells; dashed lines outline the basement membrane (Scale=50µm neo-4 
epidermis, 200µm full wound). (b) Quantification of whole wound temporal arginase activity. 5 




  3day  incisional 6 
wounds (dashed lines indicate wound margins; scale=250µm) and (d) wound area 7 
quantification. (e) Representative K14 staining of 3day wounds (solid lines indicate degree of 8 
epidermal closure, dashed lines indicate the path to re-epithelialization, scale=200µm) and (f) 9 
quantification of re-epithelialization. (g) Microarray analysis of neo-epidermal gene 10 




 wounds. Mean±SEM; 11 
n=4-6 mice/group; *p<0.05; ordinary two-way ANOVA with Sidaks multiple comparisons 12 
(b, d), Mann-Whitney U (f).  13 
 14 
Figure 4. Arginase1 is important in regulation of epidermal activation and proliferation. 15 




 wounds at 3days 16 
post-wounding. Open arrows indicate the wound edge; solidarrows indicate the cessation of 17 
K6 expression (Scale=100µm). Enumeration of  K6 (b) distance from wound edge and (c) 18 
neo-epidermal expression. (d) Representative Ki67 staining of K14cre;Arg1
wt/wt
 and 19 
K14cre;Arg1
fl/fl
 wounds, illustrating the neo-epidermis (scale=50µm) and the wound edge 20 
(500µm distance from black arrow, scale=20µm) at 3days post-wounding and the peri-wound 21 
edge (500-1000µm from black arrow, scale=20µm) at 7days post-wounding. (e) 22 
Quantification of neo-epidermal proliferation and (f) proliferating, Ki67 positive, basal 23 










n=5-6 mice/group; *p<0.05; Mann-Whitney U (b-c), or *p<0.05, **p<0.01, ***p<0.001; 1 
ordinary two-way ANOVA with Sidak’s multiple comparison (e-h).  2 
 3 
Figure 5. Arginase1 is important in regulation of epidermal differentiation. (a) 4 
Representative IF illustrating co-localization (arrowed) of arginase1 and differentiation 5 
markers  K10, filaggrin and loricrin at the epidermal wound edge of K14cre;Arg1
wt/wt
 control 6 
mice at 5days post-wounding (Red=Keratin10/Filaggrin/Loricrin; Green=Arginase1; 7 
Blue=Dapi) (Scale=50µm; dashed lines outline the basement membrane). (b) qPCR of 8 
differentiated in vitro human keratinocytes showing ARG1 (<0.05) upregulation in line with 9 
differentiation markers KRT10, FLG andLOR. (c) Representative images ofdifferentiation 10 




 wounds 11 
(Scale=100µm) and their respective quantification (d, e) . Mean ± SEM; n = 5-6 mice/group; 12 
*p<0.05; repeated measures (b) or Mann-Whitney U (d-e).  13 
 14 
Figure 6. Manipulating the balance of arginase activity restores healing in human 15 
models of cutaneous repair. (a) Representative in vitro keratinocyte (N/TERT-1) wound 16 
closure images, 10 hours post scratch, treated with arginase inhibitor nor-NOHA (5µM) 17 
and/or putrescine (10µM) with (b) quantification of percentage wound closure. (v) 18 
Quantification of wound closure of nor-NOHA (10µM) and/or Putrescine (100µM) treated 19 
human skin explants, 3days post-wounding with.(d)  representative images wholemount 20 
stained with K14. Mean ± SEM; n = 5-7/group; *p<0.05, **p<0.01, ***p<0.001 vs control; 21 
repeated measures two-way ANOVA with Sidak’s multiple comparisons (b) or ordinary one-22 








Supplementary Figure S1. Arginase1 expression in unwounded murine skin. Representative epidermal 
arginase1 expression in unwounded C57BL/6 mouse skin (dashed line indicates basement membrane; 
Scale bar = 10μm; n=2).  
Supplementary Figure S2. Epidermal arginase1 expression in age associated delayed murine healing. 
Epidermal arginase1 expression in an aged (18 months) versus young (7 weeks) murine incisional wound 
model of delayed healing at 3 days post wounding. Single colour images of Figure 2C. Yellow arrows 
indicate arginase1 positive epidermal staining. White arrows indicate the wound edge and dashed white 
lines outline the basement membrane (Red=K14; Green=Arginase1; Blue=Dapi; Scale bar = 50μm; n=5 
mice/group).  
Supplementary Figure S3. Normal skin phenotype of epidermal arginase1 depleted mice. 
Representative H+E (scale = 100μm) and IHC stained (keratin 14; keratin 10; loricrin; keratin 6; Ki67; 
(scale = 50μm) and TUNEL (scale = 20μm) images of K14cre;Arg1wt/wt and K14cre;Arg1fl/fl normal skin; 
n= 5 mice/group.  
Supplementary Figure S4. Wound immune response to epidermal arginase1 deletion. Quantification of 
(A) neutrophils, (B) macrophages and (C) arginase1 expressing dermal cells over a time course of 3 and 7 
days post wounding reveals an altered immune response in K14cre;Arg1fl/fl wounds compared to 
K14cre;Arg1wt/wt control wounds. (D-F) Microarray analysis of neo-epidermal 3 day wound tissue 
shows alterations in immune associated gene transcription of K14cre;Arg1fl/fl wounds compared to 
K14cre;Arg1wt/wt control wounds. Mean+SEM; n=5-6 mice/group; **p <0.01, ***p<0.001; Mann-
Whitney U (A-C).  
Supplementary Figure S5. Arginase inhibition delays keratinocyte scratch closure in vitro. (A) 
Quantification of HaCaT temporal arginase activity, shows a trend towards a reduction in arginase 
activity 48 hour post scratch wounding, determined by urea production. (B) Quantification of HaCaT 
scratch closure following nor-NOHA treatment compared to control and (C) representative crystal-violet 
stained HaCaT wounds after nor-NOHA treatment (yellow line indicates migrating wound edge). 
Mean±SEM; n = 3/4/group; NS = ordinary one-way ANOVA with Tukey’s multiple comparisons (A) or 
**p<0.01 Kruskal Wallis test with Dunn’s multiple comparisons (B).  
Supplementary Figure S6. Altered metabolism of arginine by arginase in cutaneous healing. (Graphical 
Abstract) (A) Normal homeostasis and wound re-epithelialisation (blue outline). (B) Inhibition of 
arginase allows greater NOS metabolism and reduced polyamine synthesis, leading to reduced wound 
edge keratinocyte proliferation and migration impacting re-epithelialisation and differentiation (red 
arrows). (C) Downstream activation of the arginase pathway with putrescine decreases wound closure 
impacting cell migration (green arrows/outline). B and C combined restores healing as A. Abbreviations; 
NOS _ nitric oxide synthase; NOHA _ N-hydroxy-L-arginine; Nor-NOHA - N-hydroxy-nor-arginine; NO _ 
nitric oxide; ODC _ ornithine decarboxylase; AMD1 - Sadenosylmethionine decarboxylase proenzyme; 
SPDS _ spermidine synthase; SMS _ spermine synthase; SAT1 _ diamine acetyltransferase 1; PAOX _ 




















ARG1 AAGATTCCCGATGTGCCAGG GTCCACGTCTCTCAAGCCAA 87 
LOR CTCACCCTTCCTGGTGCTTT GGGTGGGCTGCTTTTTCTGA 73 





FLG2 GCAAGCTGCATCAGGCTTTA CACTTCTCAAGAGGTCGGTCA 90 
 
 
Supplementary Table S2. IHC and IF primary antibodies 
 
Primary Antibody Product Number Company 
anti-liver arginase goat polyclonal ab92274 Abcam, Cambridge, UK 
anti-arginase1-I goat polyclonal SC-18354 Santa Cruz Biotechnology, 
Heidelberg, Germany 
anti-NOS2 rabbit polyclonal SC-651 Santa Cruz Biotechnology, 
Heidelberg, Germany 
anti-keratin6 rabbit polyclonal PRB-169P Covance, Maidenhead, UK 
anti-keratin14 rabbit polyclonal PRB-155P Covance, Maidenhead, UK 
anti-loricrin rabbit polyclonal PRB-145P Covance, Maidenhead, UK 
anti-keratin10 rabbit polyclonal 905404 Biolegend, CA, USA 
anti-filaggrin rabbit polyclonal Ab24584 Abcam, Cambridge, UK 
anti-Ki67 rabbit monoclonal Ab16667 Abcam, Cambridge, UK 
anti-neutrophil rat polyclonal MA1-40038 ThermoFisher Scientific, 
Loughborough, UK 










MATERIALS AND METHODS 
 
Human acute and chronic wounds 
Acute wound samples were collected from 3 healthy volunteers (male, aged ≥30 years). 
Briefly, 1.5 mm punch biopsies were taken from the left upper inner arm following local 1% 
lignocaine infiltration. This initial biopsy was excised using a second 3 mm biopsy. Chronic 
wound biopsy samples were used from 19 patients (mixed sex, aged ≥40 years) with chronic 
DFU (defined as distal to the medial and lateral malleoli, with a known duration ≥4 weeks, 
grade A1/B1 according to the University of Texas ulcer classification, no infection or 
ischaemia at the time of presentation) as previously described. All patients received standard-
of-care treatment, including regular debridement, non-anti-microbial dressings and 
offloading. No local anaesthetic was used at any time during treatment. At presentation, 
wound biopsy samples were collected from the margin of DFUs prior to debridement using 
sterile technique. Patients were followed for a period of 12 weeks (via weekly visits to the 
diabetic clinic), with photographs taken at each visit to determine longitudinal healing 
outcome using wound traces and calculating the wound area with ImageJ 1.x software 
(ImageJ, Maryland, USA). DFUs were then separated into two groups, those who healed (full 
wound closure at ≤7 weeks; 6 patients) and those who failed to heal (wound not closed at 12 
weeks; 13 patients) following current best practice treatment. Samples were fixed and 
processed for histological analysis.   
 
Conditional arginase1 knockout mouse model 
Following local ethics committee approval, all animal studies were conducted in accordance 








under the same conditions at the University of Manchester’s Biological Services Facility, 
housed in isolator cages with ad libitum food and water. The room was maintained at a 
constant temperature of 21°C, with 45-65% humidity on a 12 hour light-dark cycle. K14-
cre;Arg1
fl/fl
 mice were generated in house by crossing an arginase1 floxed mouse (El Kasmi 
et al., 2008) with a  K14cre expressing mouse (Li M. et al., 2001) and K14-cre;Arg1
wt/wt 
mice 
were used as cre positive controls (all C57BL/6J background). Transgenic mice were bred 
onsite from homozygous mating. Genotype was determined by PCR (see Genotyping 
supplemental section) and cell specific deletion confirmed by IHC. IHC results confirmed a 





 controls. The specificity of the knockout was also 
demonstrated by retained dermal arginase1 expression in K14cre;Arg1
fl/fl
 mice (Figure 3a).  
 
Genotyping 
Mice were genotyped by PCR using three sets of primers (Invitrogen, Loughborough, UK); 
arg flox [F- TGCGAGTTCATGACTAAGGTT; R- AAAGCTCAGGTGAATCGG; wt200bp; 
floxed230bp]; k14 cre [F- ATTTGCCTGCATTACCGGTC; R- 
ATCAACGTTTTGTTTTCGGA; 349bp]; and deletion confirmation [F-
CCCCCAAAGGAAATGTAAGAA; R- CACTGTCTAAGCCCGAGAGTA; 500bp] and HS 
MyTaq Red mastermix (Bioline). Reactions were performed using a SimpliAmp Thermal 
Cycler (Applied Biosystems, Loughborough, UK) using the following cycling parameters; 
Initial denaturation (95°C 3min); 40x cycles 1. Denaturation (94°C 45sec) 2. Annealing 
(53°C arg flox or 55°C delta and k14 cre 45sec) 3. Elongation (72°C 1min); Final extension 
(72°C 5min). PCR products were run on a standard 2% agarose gel (Bioline, London, UK). A 
















Quantitative real-time PCR 
In brief, cDNA was transcribed from 0.5μg of RNA using the GoScript RT kit (Promega, 
Madison, WI) and quantitative PCR performed using the PowerUp Sybr Green Master Mix 
(Thermo, UK) and LightCycler 480 Instrument (Roche, UK). For each primer set, an optimal 
dilution was determined and melt curves were used to determine amplification specificity. 
Each sample was performed in triplicate and relative expression was determined from a 
standard curve. Expression ratios were normalized to the housekeeper YWHAZ. Full primer 
sequences are listed in Supplementary Table S1. 
 
IHC and IF image analysis 
All antibodies used are listed in Supplementary Table S2. Images were acquired on a 3D-
Histech Pannoramic-250 microscope slide-scanner using a 20x/ 0.80 Plan Apochromat 
objective (Zeiss, Cambridge, UK) and the DAPI, FITC and TRITC filter sets for fluorescence 
imaging. Snapshots of the slide-scans were taken using the Case Viewer software (3D-
Histech). Images were also acquired using manual microscopes; a Nikon Eclipse E600 
microscope and a SPOT insight camera (Image solutions Inc, Preston, UK); or a Nikon 
Eclipse Ci microscope using 4x/0.13; 10x/0.30; 20x/0.50 or 40x/0.75 Plan Fluor objectives, 
with a Nikon DS-Fi3 camera and NIS-Elements software (Nikon, Kingston Upon Thames, 
UK). Quantification of wound measurements and cell counts were performed using Image 
Pro Premier software (Media Cybernetics, Abingdon, UK) as described previously (Williams 








wound width and percent re-epithelialization (confirmed with K14 stained sections). The 
wound area was considered the area of granulation tissue beneath the clot to the margins of 
normal skin either side of the wound. Percent re-epithelialization was determined by dividing 
the sum length of each neo-epidermal tongue by the total distance required to fully close the 
wound. K6 staining was quantified by area measurements of the neo-epidermal tongue and 
the length of K6 staining away from the wound edge, taken as an average of each side per 
wound. Ki67 IHC was quantified by cells/neo-epidermal area. Basal Ki67 expression was 
manually counted as a percentage of positive and total basal keratinocytes, measured at the 
wound edge (0-500µm distance from the wound edge) and the peri-wound edge (500-
1000µm distance from the wound edge). Cell counts within the wound area were determined 
using 5 representative images of the granulation tissue at x20 magnification. Keratin 10 and 
Loricrin staining were quantified based on a subjective scoring system out of 10; 0 being no 
positive staining in the newly formed epidermis and 10 being as normal skin. Arginase1 
staining was quantified, as an average score from x20 magnification images of the entire 
epidermis of DFU sections or neo-epidermal/wound edge regions of acute mouse wounds, 
based on a subjective scoring system out of 10 for both epidermal coverage (IHC) or stain 
intensity (IF) (0 = no expression; 10 = full coverage or high intensity). All staining and 
quantification was performed blind. 
 
TUNEL staining  
Briefly, rehydrated tissue sections were incubated in Proteinase K (20µg/ml proteinase K in 
10mM Tris/HCl pH 7.5) for 20min at 37°C, followed by washing in PBS. Sections were 
incubated in TUNEL reaction mixture (1:10 Enzyme Solution: Label Solution) or Label 
Solution as a negative control, in the dark for 30min at 37°C. After washing, sections were 








washed and mounted using Prolong Gold Antifade Mounting Media (ThermoFisher 




Arginase activity assay 
In brief, normal skin and wound tissue was homogenized in 0.1% Triton X-100 (Sigma). 
After 30min, samples were centrifuged for 1min at 8000g to pellet cell debris. Assay buffer 
(10mM MnCl in 50mM Tris, pH 7.5) was added to the supernatant for 10 minutes at 56°C. 
Samples were incubated with the arginase substrate L-arginine (0.5M L-Arginine pH9.7) for 
3hrs at 37°C before adding acid stop solution (H2SO4, (Sigma) : H3PO4 (Sigma) : H20 in 1:3:7 
ratio (v/v)). 9% α-isonitrosopropiophenone (Sigma) was added and samples heated at 100°C 
protected from light. Absorbance was measured after 45min at 570nm (VersaMax microplate 
reader, Molecular Devices LLC) and urea concentration was calculated against a standard 
curve. Total protein concentration in the cell lysates was determined by the Pierce 660nm 
Protein Assay (ThermoFisher Scientific) to normalize each sample. 
 
Laser Capture Microscopy (LCM) 
Day 3 incisional wounds (n=4/group) were snap frozen upon tissue harvest and OCT 
embedded prior to cryosectioning. 10µm thick cryosections were obtained using a clean 
RNase free designated CM3050 cryostat (Leica Biosystems) and mounted onto RNase free 
MMI MembraneSlides, inverted and placed onto a glass slide for protection against 
contamination. Samples were dehydrated in isopropanol (30sec) and xylene (30sec) and air 
dried immediately prior to LCM. Samples were laser microdissected using the MMI CellCut 








the MMI software, cells of the neo-epidermis were marked and cut automatically using a 
20x/0.45 Plan FL N objective and UV-Laser at 60% power; speed of 18µm/s; focal point of 
350.  The isolated target cells were collected from the MMI Membrane Slides by lowering 
and lifting of the adhesive cap of 0.5ml MMI Isolation Caps (Olympus) held from 
above. Captured samples were stored in  Lysis Solution (Ambion RNAqueous-Micro Kit 
component) inverted on ice then stored at -80°C until ready for RNA isolation.  
 
Microarray 
Data was provided to the Bioinformatics core facility in the Faculty of Biology Medicine and 
Health, University of Manchester, for analysis as follows. Technical quality control and 
outlier analysis was performed with dChip (V2005) (Li and Wong, 2001) using the default 
settings. Mouse Transcriptome Assay 1.0 data were processed and analysed using Partek 
Genomics Solution (version 6.6, Copyright 2009, Partek Inc., St. Charles, MO, USA) with 
the following options: probesets were quantile normalized and RMA background correction 
applied. Probesets were summarized to genes by calculating the means (log 2). Validation 
and gene enrichment strategies consisted of the following steps. Step 1, to establish 
relationships and compare variability between replicate arrays and experimental conditions, 
principal components analysis (PCA) was used. PCA was chosen for its ability to reduce the 
effective dimensionality of complex gene-expression space without significant loss of 
information (Quackenbush, 2001). Step 2, Differential expression analysis was performed on 
annotated genes with Limma using the functions lmFit and eBayes (Smyth, 2004). Gene lists 
of differentially expressed genes were controlled for false discovery rate (fdr) errors using the 
Benjamini–Hochberg procedure (Team, 2008). Step 3, functional annotation of gene lists 
containing significantly differentially expressed genes was done with QIAGEN’s Ingenuity 








fold change +/-1.25 and p value <0.05. Supplemental data presented is unfiltered by fold 
change with a p value <0.05. Raw data was deposited in ArrayExpress 
(accession  number: E-MTAB-10213). 
 
In vitro cell analysis 
Keratinocyte culture 
Normal human epidermal keratinocytes (NHEKs) isolated from juvenile foreskin (Promocell) 
were cultured in keratinocyte growth medium 2 (Promocell) at 37°C with 5% CO2. NHEKs 
were used in experiments at P3-5. N/TERT-1 cells were cultured at 37°C with 5% CO2 in 
Keratinocyte Serum Free Media (Complete KSFM:  low Ca2+ (500µl of 300mM) K-SFM 
(with 25µg/ml BPE, 0.2ng/ml EGF, 5ml Pen/Strep) and transferred to DFK-2 media (50:50 
ratio of DFK-1 media (DMEM (high glucose), F-12 , 25µg/ml BPE, 0.2ng/ml EGF, 5ml L-
glutamine, 5ml Pen/Strep) and K-SFM,all from GIBCO). HaCaT cells (ATCC12191) were 
cultured in DMEM (high glucose) with 10% FBS and 1x Pen/Strep at 37°C with 5% CO2. 
 
Human skin wound explant model 
Briefly, adult female abdominal skin (Caucasian, aged ≥50 years from four donors) was 
washed in sterile PBS and excess fat removed. 3mm partial thickness wounds were generated 
within 8mm diameter biopsy-punched constructs. Biopsies were cultured within 6well plates, 
placed on a stack, consisting of a 0.45µm nylon membrane on top of 2x absorbent pads, 
saturated with 1ml of Williams E media + supplements (100U Penicillin and 0.1mg 
Streptomycin per ml, 2mM l-glutamine, 10µg/ml insulin, 10ng/ml hydrocortisone (Sigma)). 
10µl nor-NOHA 10µM (Cayman, Michigan, USA) or Putrescine 100µM (Sigma) was 
applied directly to the wound. Biopsies were maintained at 37°C, 5% CO2 for 3 days, media 








keratin 14 antibody. Images were obtained using a stereo microscope (Leica) and camera 
(Leica) and wound re-epithelialization was determined by calculating the remaining wound 
area as a percentage of the initial wound area, measured using Image Pro Premier software 
(Media Cybernetics, Abingdon, UK). 
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